市場調査レポート

商品コード

1633685

医薬品検査の市場規模、シェア、成長分析：製品別、サンプル別、薬物別、最終用途別、地域別 - 産業予測 2025～2032年

Drug Testing Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Sample (Urine Samples, Oral Fluid Samples), By Drug, By End Use, By Region - Industry Forecast 2025-2032

出版日: 2025年01月11日
発行: SkyQuest
ページ情報: 英文 171 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 3,500 513,870円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 4,400 646,008円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 5,300 778,146円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
目次

概要

サンプル依頼リストに入れる

医薬品検査の世界市場規模は2023年に59億米ドルとなり、予測期間（2025-2032年）のCAGRは5.2%で、2024年の62億1,000万米ドルから2032年には93億1,000万米ドルに成長する見通しです。

医薬品検査市場は、アルコールと医薬品検査の安全性への懸念に対処するための政府機関からの規制要求の高まりによって、大きな成長が見込まれています。薬物中毒の監視と予防に向けた継続的な取り組みが、この動向をさらに際立たせています。さらに、COVID-19の大流行が精神衛生に与える影響によって悪化した物質誤用の世界の増加は、事業閉鎖や景気後退とともに、包括的なスクリーニングソリューションの必要性を高めています。これには、違法薬物と処方された薬物の両方、およびスポーツ選手が使用する身体強化物質の検出が含まれます。このような問題に対する意識が高まるにつれ、さまざまな生物学的サンプルに対する医薬品検査サービスの需要が急増し、市場拡大の十分な機会がもたらされると予想されます。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Laboratory Corporation of America Holdings（LabCorp）（USA）
Abbott Laboratories（USA）
Thermo Fisher Scientific Inc.（USA）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche Ltd（Switzerland）
OraSure Technologies, Inc.（USA）
Alfa Scientific Designs, Inc.（USA）
Dragerwerk AG & Co. KGaA（Germany）
Randox Testing Services（UK）
United States Drug Testing Laboratories, Inc.（USDTL）（USA）
Psychemedics Corporation（USA）
Cordant Health Solutions（USA）
Omega Laboratories, Inc.（USA）
Clinical Reference Laboratory, Inc.（USA）
Premier Biotech, Inc.（USA）
Danaher Corporation（USA）
Bio-Rad Laboratories, Inc.（USA）
Shimadzu Corporation（Japan）
Lifeloc Technologies, Inc.（USA）

結論と推奨事項

Product Code: SQMIG35D2032

Global Drug Testing Market size was valued at USD 5.9 billion in 2023 and is poised to grow from USD 6.21 billion in 2024 to USD 9.31 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The drug testing market is poised for significant growth, driven by increasing regulatory demands from government agencies for alcohol and drug testing to address safety concerns. The ongoing efforts to monitor and prevent substance addiction further underscore this trend. Additionally, the global rise in substance misuse, exacerbated by the mental health impact of the COVID-19 pandemic-along with business closures and economic downturns-has heightened the need for comprehensive screening solutions. This includes the detection of both illicit and prescribed medications, as well as performance-enhancing substances used by athletes. As awareness of these issues grows, the demand for drug testing services across various biological samples is expected to surge, presenting ample opportunities for market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Testing Market Segmental Analysis

Global Drug Testing Market is segmented by Product, Sample, Drug, End Use and region. Based on Product, the market is segmented into Consumables, Instruments, Rapid Testing Devices and Services. Based on Sample, the market is segmented into Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples. Based on Drug, the market is segmented into Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD and Others. Based on End Use, the market is segmented into Drug Testing Laboratories, Workplaces, Hospitals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Testing Market

The primary driver propelling the growth of the Global Drug Testing market is the rising rates of drug and alcohol consumption globally. Reports indicate a significant increase in substance abuse, with approximately 275 million individuals aged 15-64 using drugs at least once in 2019, according to the World Drug Report 2021. This troubling trend led to around 36.3 million people grappling with drug dependence, causing substantial health and societal issues, including nearly 500,000 fatalities and the loss of 18 million years of healthy life linked primarily to opioid use. The escalating prevalence of drug and alcohol abuse, notably concerning impaired driving incidents, underscores the urgent need for effective drug testing solutions, thereby driving demand for drug screening products and services, which is expected to significantly enhance overall market growth.

Restraints in the Global Drug Testing Market

The growth of the Global Drug Testing market is expected to be hindered by prohibitions on workplace drug testing in several countries. Nations such as Canada, Colombia, Argentina, Chile, and South Africa view these testing practices as violations of employee privacy. In France, for instance, pre-employment drug testing is only permitted under a physician's prescription. Meanwhile, countries like Poland and the Czech Republic have deemed workplace drug and alcohol testing illegal. Additionally, specific regulations in Eastern Canada allow for such testing solely in high-risk occupational scenarios or select situations. These restrictions in various regions could significantly constrain the overall development and acceptance of drug and alcohol testing in their respective markets.

Market Trends of the Global Drug Testing Market

The Global Drug Testing market is witnessing a significant shift towards innovative, non-invasive solutions, particularly driven by the emergence of fingerprint-based drug testing. Accelerated by the COVID-19 pandemic, this technology offers a hygienic, portable, and rapid alternative to traditional methods, addressing safety concerns associated with viral transmission in clinical settings. As organizations increasingly adopt fingerprint analysis for its ease of use and minimal sample collection requirements, the method demonstrates potential for wider application in workplaces, law enforcement, and rehabilitation programs. This evolving landscape presents substantial growth opportunities for industry players, positioning fingerprint-based tests as a future replacement for conventional urine, hair, and blood tests.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Drug Testing Market Size by Product & CAGR (2025-2032)

Market Overview
Consumables
Instruments
Rapid Testing Devices
Services

Global Drug Testing Market Size by Sample & CAGR (2025-2032)

Market Overview
Urine Samples
Oral Fluid Samples
Hair Samples
Other Samples

Global Drug Testing Market Size by Drug & CAGR (2025-2032)

Market Overview
Alcohol
Cannabis/Marijuana
Cocaine
Opioids
Amphetamine & Methamphetamine
LSD
Others

Global Drug Testing Market Size by End Use & CAGR (2025-2032)

Market Overview
Drug Testing Laboratories
Workplaces
Hospitals
Others

Global Drug Testing Market Size & CAGR (2025-2032)

North America (Product, Sample, Drug, End Use)
- US
- Canada
Europe (Product, Sample, Drug, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Sample, Drug, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Sample, Drug, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Sample, Drug, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Laboratory Corporation of America Holdings (LabCorp) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alfa Scientific Designs, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Testing Services (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
United States Drug Testing Laboratories, Inc. (USDTL) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Psychemedics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordant Health Solutions (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinical Reference Laboratory, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Premier Biotech, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifeloc Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

医薬品検査の市場規模、シェア、成長分析：製品別、サンプル別、薬物別、最終用途別、地域別 - 産業予測 2025～2032年

Drug Testing Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Sample (Urine Samples, Oral Fluid Samples), By Drug, By End Use, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

医薬品検査市場規模：製品別& CAGR（2025-2032）

医薬品検査市場規模：サンプル別& CAGR（2025-2032）

医薬品検査市場規模：薬物別& CAGR（2025-2032）

医薬品検査市場規模：最終用途別& CAGR（2025-2032）

医薬品検査市場規模：地域別& CAGR（2025-2032）